MEMPHIS, Tenn.--(BUSINESS WIRE)--arGentis Pharmaceuticals, LLC has selected Target Health, Inc. as its Clinical Research Organization (CRO) partner for their upcoming clinical trials. With clinical trial costs increasing dramatically, it has been demonstrated that the selection of a quality CRO provides cost saving opportunities for their drug sponsors. Utilizing Target Health’s global expertise across multiple therapeutic categories will allow arGentis to expand development capacity without requiring an increase in staff or facilities.
